| (EUR) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 78.49B | — |
| Operating expense | — | — |
| Net income | 20.99B | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, NOV.DE returned +21.3% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +34.0% |
| 1 year | +21.3% |
| 5 years | +133.1% |
| 10 years | +1104.9% |
| All-time high | €134.52 (Jun 2024) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what €1,000 in NOV.DE would be worth today ›Yes. Novo Nordisk A/S paid 2 dividends over the past 12 months. The most recent was €0.50 per share on Aug 14, 2026. The dividend yield is 3.90%.
Novo Nordisk A/S is part of the Healthcare sector.
Novo Nordisk A/S has a market cap of 176.99B EUR, based on the latest quote.
Novo Nordisk A/S is expected to report earnings around Nov 4, 2026. That date is an estimate and has not been confirmed by the company.
